Holista Colltech Limited · ASX:HCT
Holista Colltech — Shareholder Meeting (July 2021)
18 slides from Holista Colltech's shareholder meeting presentation, July 2021
Slide 1: AGM Presentation July 2021
AGM Presentation July 2021 HOLISTA COLLTECH
Slide 2: Company Overview (ASX: HCT)
Company Overview (ASX: HCT) World-leading technologies & global reach Holista Colltech is an emerging ✓Global reach with customers in Asia, US and Australia Australian developer of unique health and wellness products in the ✓Successfully commercialised portfolio of patent- US$4.5 trillion Global Hea
Slide 3: Resilient 2020 Revenue, Improved outlook
Resilient 2020 Revenue Improved outlook 2020 full-year revenue steady at $7.1m despite COVID-19 global crisis. Healthy Food Ingredients sales continues to grow strongly on the back of orders from Costanzo’s Infection Control Solutions delivered maiden contribution to Group results Collagen and Dieta
Slide 4: Global Revenue FY2020: Diversifying the income base
Global Revenue FY2020 Diversifying the income base Infection Control Growth potential in Ovine Collagen, Infection Food Ovine $0.67m Ingredients Control and Food Ingredients Collagen $1.03m $0.17m Infection Control is newest division and its first year contribution (FY20) accounted for ~10% of Group
Slide 5: Sales Growth Across All Divisions
Sales Growth Across All Divisions Continuing growth momentum Divisional Sales Revenue* ($K) Total 1H21 Group Sales 4000 increased by 29.2% to $3.6 3500 million* compared to 1H20 with all divisions contributing to 3000 the improved results 2500 2000 Division PCP Change 1500 Food Ingredients 158.9% 10
Slide 6: Year of Achievements
Year of Achievements Foundations for a stronger FY21 1st order Exclusive received Launch “List distribution for SARS- N” HVAC agreement CoV-2 test 1st order for solution to for ovine kits GI-LiteTM control collagen Path- from into China airborne Away® Costanzo’s Signs deal COVID successfully for US
Slide 7: Business Divisions
Business Divisions Growth engines • Fastest growing •Newest business •Largest •1st to produce Ovine Collagen Dietary Supplements Infection Control Solutions Healthy Food Ingredients division in FY21 (FY20 1st year sales/profit ovine collagen • Momentum contribution) contributor from Australian expec
Slide 8: Healthy Food Ingredients Developments & update
Healthy Food Ingredients Developments & update Costanzo’s launched world’s lowest GI clean-label white bread in the US Holista has a full range of low GI foods, using Holista’s GI LiteTM in April 2021 tested and validated by the University of Sydney* Costanzo’s Low GI White Bread sold in US in super
Slide 9: Infection Control Developments & update: NatShield & Path-Away
Infection Control Developments & update NatShieldTM & Path-Away® ✓Secured distribution rights for Path-Away (active ingredient in NatShield) and acquired Protectene® from GICC ✓Microbac tests shows Path-Away kills 99.9% of COVID-19 virus (SARS-CoV-2) within 2 minutes ✓Undertaking studies to show Pat
Slide 10: Infection Control Developments & update: M3 HVAC Solution
Infection Control Developments & update M3® HVAC Solution ✓Signed term sheet to form JV with GICC to pursue opportunities outside of North America ✓M3 exempted in Australia for heating, ventilation and air-conditioning (HVAC) application ✓Submitted TGA application for “List N” Bioesque formulated wi
Slide 11: Infection Control: Latest Revenue Stream
Infection Control Latest Revenue Stream COVID-19 Test Kits ✓Secured exclusive distribution rights to 15min rapid test kits made by Guangdong Hecin Scientific Inc ✓Approved in Malaysia (Emergency Use Authorisation) ✓Won first order in Malaysia last month to supply 15,000 test kits with ongoing follow
Slide 12: Dietary Supplements Developments & update
Dietary Supplements Developments & update Sales increased by +9% in 1H 2021 v 1H 2020 Growth driven by rebound from COVID and launch of two new supplements “Cash Cow” business that contributed ~70% of 2020 Group revenue Global Supplement market growing at 8.6% CAGR* from 2021-2028* * Source: https:/
Slide 13: US Sales Rebounding Strongly
US Sales Rebounding Strongly iGalen restructure and relaunch iGalen is Holista’s global distribution partner US$ iGalen Month-on-Month Cumulative Sales ✓ iGalen relaunched in August 2020 800,000 ✓ Sales recovery with good margin driven by creative 700,000 marketing and use of key influencers (e.g. f
Slide 14: Ovine Collagen Developments & update
Ovine Collagen Developments & update Guangzhou Sinbio Cosmetic Co Ltd trialling Holista’s patented Guangzhou Sinbio is a collagen (via agreement with Mutiara Seribumi) Chinese state-owned enterprise that exclusively Sinbio to purchase 100% of Holista’s 48-tonne annual production represents leading c
Slide 15: Board of Directors & Advisors
Board of Directors & Advisors Expertise to lead the group forward Daniel O’Connor Rajen Manicka Walter Joseph Arthur Martin Roscoe Moore Non-Exec Chairman MD & CEO Non-Executive Director Advisor Advisor Over three decades Dr Manicka spent nine Successful track record Founder and President of Dr Moor
Slide 16: Positive Outlook
Positive Outlook Improved 2021 results expected Healthy Food Infection Control • Improved demand for GI- ✓ Improving Outlook: YTD trading LiteTM and 80LessTM • Additional growth opportunities from new conditions show marked improvement • Growing consumer focus products (M3, Nasal over 2020 on health
Slide 17: Thank You
To join our mailing list please email: update@holistaco.com Thank You For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com Investor/Media Relations: Brendon Lau (m: 0409 341 613, e: brendon@vantagepointpartners.com.au)
Slide 18: Disclaimer
Disclaimer This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. The presentation is for information purposes only and does not constitute or form part of any offer or invitation